What is the Fiscal Year for Hoth Therapeutics?
Date: November 14, 2026
Hoth Therapeutics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
New York, United States
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
HOTH
Website
https://hoththerapeutics.comDescription
Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on next-generation therapeutics to address unmet patient needs. As a catalyst in early-stage pharmaceutical research and development, we advance promising drugs from the lab to clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate medications that hold immense potential to create breakthroughs and diversify treatment options. Our pipeline spans oncology, dermatology, neurology, and more.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Hoth Therapeutics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.